Timeline

Voting rights breakdown

Notice details

Beneficial owner

ADDEX THERAPEUTICS LTD

Addex Therapeutics Ltd signed a lock-up agreement. The registered shares are blocked until March, 8 2021, except 100,000 shares. The lock-up agreement is part of the underwriting agreement committing investors to participate in the capital increase described in the prospectus disclosed on January 8, 2021 The disclosure of this shareholdings is triggered by the constitution of a lock-up Group and the signature of an underwriting agreement planning the capital increase disclosed in the prospectus. The capital increase has been processed on January 8 2021 and published in the SHAB on January 12 2021.